Molecular dynamic approach in the regulation of systemic XCT antiporter through biologically active molecules for ischemic stroke

References

• Sangwan N, Avti PK. Nanomedicine-Mediated stem cell therapeutics in stroke. In: Raza SS, editor. Regenerative therapies in ischemic stroke recovery. Singapore: Springer; 2022. doi:10.1007/978-981-16-8562-0_7
   Google Scholar
• Sarikaya H, Ferro J, Arnold M. Stroke prevention - medical and lifestyle measures. Eur Neurol. 2015;73(3-4):150–157. doi:10.1159/000367652
   PubMed Web of Science ®Google Scholar
• Crack PJ, Taylor JM. Reactive oxygen species and the modulation of stroke⋆. Free Radic Biol Med. 2005;38(11):1433–1444. doi:10.1016/j.freeradbiomed.2005.01.019
   PubMed Web of Science ®Google Scholar
• Doeppner TR, Hermann DM. Free radical scavengers and spin traps – therapeutic implications for ischemic stroke. Best Pract Res Clin Anaesthesiol. 2010;24(4):511–520. doi:10.1016/j.bpa.2010.10.003
   PubMedGoogle Scholar
• Ren JX, Sun X, Yan XL, et al. Ferroptosis in neurological diseases. Front Cell Neurosci. 2020;14:218. doi:10.3389/fncel.2020.00218
   PubMed Web of Science ®Google Scholar
• Zhang Y, Lu X, Tai B, et al. Ferroptosis and its multifaceted roles in cerebral stroke. Front Cell Neurosci. 2021;15:615372. doi:10.3389/fncel.2021.615372
   PubMed Web of Science ®Google Scholar
• Bridges RJ, Natale NR, Patel SA. System xc-Cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS. Br J Pharmacol. 2012;165(1):20–34. doi:10.1111/j.1476-5381.2011.01480.x
   PubMed Web of Science ®Google Scholar
• Lewerenz J, Hewett SJ, Huang Y, et al. The Cystine/glutamate antiporter system xc− in health and disease: from molecular mechanisms to novel therapeutic opportunities. Antiox Redox Signal. 2013;18(5):522–555. doi:10.1089/ars.2011.4391
   PubMed Web of Science ®Google Scholar
• Parker JL, Deme JC, Kolokouris D, et al. Anomalous collapses of Nares Strait ice arches leads to enhanced export of Arctic sea ice. Nat Commun. 2021;12(1):1–1. doi:10.1038/s41467-020-20314-w
   PubMed Web of Science ®Google Scholar
• Errasti-Murugarren E, Fort J, Bartoccioni P, et al. L amino acid transporter structure and molecular bases for the asymmetry of substrate interaction. Nat Commun. 2019;10(1):1–2. doi:10.1038/s41467-019-09837-z
   PubMedGoogle Scholar
• Sangwan N, Singh J, Chauhan A, et al. Terpenoid analogues as putative therapeutic agents towards glutathione peroxidase (GPX4) in neurodegenerative disorders: a dynamic computational approach. J Biomol Struct Dyn. 2023;41:5436–5446. doi:10.1080/07391102.2022.2086923
   PubMed Web of Science ®Google Scholar
• Yan HF, Tuo QZ, Yin QZ, et al. The pathological role of ferroptosis in ischemia/reperfusion-related injury. Zool Res. 2020;41(3):220. doi:10.24272/j.issn.2095-8137.2020.042
   PubMed Web of Science ®Google Scholar
• Vallerga CL, Zhang F, Fowdar J, et al. Analysis of DNA methylation associates the cystine–glutamate antiporter SLC7A11 with risk of Parkinson’s disease. Nat Commun. 2020;11(1):1. doi:10.1038/s41467-020-15065-7
   PubMed Web of Science ®Google Scholar
• Sangwan N, Singh J, Chauhan A, et al. Structure and dynamic simulation-based interactions of benzenoids, pyrroles and organooxygen compounds for effective targeting of GPX4 in ischemic stroke. J Biomol Struct Dyn. 2022;30:1–4.
   Google Scholar
• Singh J, Raina A, Sangwan N, et al. Structural, molecular hybridization and network based identification of miR-373-3p and miR-520e-3p as regulators of NR4A2 human gene involved in neurodegeneration. Nucleosides Nucleotides Nucleic Acids. 2022;41(5-6):419–443. doi:10.1080/15257770.2022.2048851
   PubMed Web of Science ®Google Scholar
• Chauhan A, Sangwan N, Singh J, et al. Allosteric modulation of conserved motifs and helices in 5HT2BR: Advances drug discovery and therapeutic approach towards drug resistant epilepsy. J Biomol Struct Dyn. 2023:–41(22):13113-13126.
   Web of Science ®Google Scholar
• Waterhouse A, Bertoni M, Bienert S, et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 2018;46:W296–W303. doi:10.1093/nar/gky427
   PubMed Web of Science ®Google Scholar
• Laskowski RA, MacArthur MW, Moss DS, et al. PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr. 1993;26:283–291. doi:10.1107/S0021889892009944
   Web of Science ®Google Scholar
• Colovos C, Yeates TO. Verification of protein structures: patterns of nonbonded atomic interactions. Protein Sci. 1993;2(9):1511–1519. doi:10.1002/pro.5560020916
   PubMed Web of Science ®Google Scholar
• Van Dijk M, Bonvin AM. 3D-DART: a DNA structure modelling server. Nucleic Acids Res. 2009;37(suppl_2):W235–W239. doi:10.1093/nar/gkp287
   PubMedGoogle Scholar
• Kanz C. The EMBL nucleotide sequence database. Nucleic Acids Res. 2004;33:D29–D33. doi:10.1093/nar/gki098
   Web of Science ®Google Scholar
• Waterhouse AM, Procter JB, Martin DMA, et al. Jalview Version 2—a multiple sequence alignment editor and analysis workbench. Bioinformatics. 2009;25:1189–1191. doi:10.1093/bioinformatics/btp033
   PubMed Web of Science ®Google Scholar
• Wass MN, Kelley LA, Sternberg MJE. 3DLigandSite: predicting ligand-binding sites using similar structures. Nucleic Acids Res. 2010;38:W469–W473. doi:10.1093/nar/gkq406
   PubMed Web of Science ®Google Scholar
• Irwin JJ, Shoichet BK. Zinc − A free database of commercially available compounds for virtual screening. J Chem Inf Model. 2005;45(1):177–182. doi:10.1021/ci049714+
   PubMed Web of Science ®Google Scholar
• Dallakyan S, Olson AJ. Small-molecule library screening by docking with PyRx. Chem Biol Methods Protocols. 2015;1263:243–250.
   Google Scholar
• Bowers KJ, Chow DE, Xu H, et al. Scalable algorithms for molecular dynamics simulations on commodity clusters. In: ACM/IEEE SC 2006 Conference (SC’06). Tampa, FL: IEEE; 2006. p. 43–43.
   Google Scholar
• Wang Z, Pan H, Sun H, et al. fastDRH: a webserver to predict and analyze protein–ligand complexes based on molecular docking and MM/PB(GB)SA computation. Brief Bioinformatics. 2022. doi/10.1093/bib/bbac201/6587180.
   Web of Science ®Google Scholar
• Sharma M, Anirudh CR. In silico characterization of residues essential for substrate binding of human Cystine transporter, xCT. J Mol Model. 2019;25(11):1–4. doi:10.1007/s00894-018-3878-2
   Web of Science ®Google Scholar
• Patel D, Kharkar PS, Gandhi NS, et al. Novel analogs of sulfasalazine as system xc− antiporter inhibitors: Insights from the molecular modeling studies. Drug Dev Res. 2019;80(6):758–777. doi:10.1002/ddr.21557
   PubMed Web of Science ®Google Scholar